These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20591366)

  • 1. Work at high altitude after coronary stenting: safe?
    Wu T; Ding S; Kayser B
    Wilderness Environ Med; 2010 Mar; 21(1):86-7. PubMed ID: 20591366
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stents versus coronary-artery bypass grafting for left main coronary artery disease.
    Seung KB; Park DW; Kim YH; Lee SW; Lee CW; Hong MK; Park SW; Yun SC; Gwon HC; Jeong MH; Jang Y; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    N Engl J Med; 2008 Apr; 358(17):1781-92. PubMed ID: 18378517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of stenting for selective unprotected left main coronary artery disease: two-year follow-up of 416 patients].
    Han YL; Wang SL; Jing QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1109-12. PubMed ID: 17672992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of stenting with sirolimus eluting stent and spot stenting with small vessel stent in treatment of small vessels with long lesions].
    Li XM; Wang S; Li B; Wang TS; Chen GL; Wang W; Ma JL; Wang Q; Su ZT
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):265-7. PubMed ID: 17425875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional result following direct coronary artery stenting with drug eluting stents in chronic stable angina is similar to stenting after balloon predilatation.
    Balachandran KP; Singh B; Sandilands A; Popusoi G; Rubino P; Baumbach A
    Int J Cardiol; 2008 Aug; 128(3):374-7. PubMed ID: 17689737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
    J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
    Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of day-case transfemoral coronary stenting.
    Dalby M; Davies J; Rakhit R; Mayet J; Foale R; Davies DW
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):18-24. PubMed ID: 12929097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of noncardiac surgery after coronary stenting.
    Reddy PR; Vaitkus PT
    Am J Cardiol; 2005 Mar; 95(6):755-7. PubMed ID: 15757604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.
    Pfisterer M; Bertel O; Bonetti PO; Brunner-La Rocca HP; Eberli FR; Erne P; Galatius S; Hornig B; Kiowski W; Pachinger O; Pedrazzini G; Rickli H; De Servi S; Kaiser C;
    Am Heart J; 2008 Apr; 155(4):609-14. PubMed ID: 18371466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease.
    Beygui F; Varnous S; Montalescot G; Fernandez F; Collet JP; Leprince P; Le Feuvre C; Pavie A; Komajda M; Metzger JP; Gandjbakhch I
    J Heart Lung Transplant; 2010 Mar; 29(3):316-22. PubMed ID: 19837605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Non-cardiac surgery and antiplatelet therapy following coronary artery stenting.
    Carmignani L; Picozzi S
    Heart; 2009 Sep; 95(18):1537; author reply 1537. PubMed ID: 19717703
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.